These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 16948223)
1. [Therapeutic perspectives in multiple sclerosis]. Lubetzki C Rev Prat; 2006 Jun; 56(12):1347-52. PubMed ID: 16948223 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination. Paz Soldan MM; Rodriguez M J Infect Dis; 2002 Dec; 186 Suppl 2():S248-53. PubMed ID: 12424705 [TBL] [Abstract][Full Text] [Related]
3. Specific treatment of multiple sclerosis. Silberberg DH Clin Neurosci; 1994; 2(3-4):271-4. PubMed ID: 7749898 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies in multiple sclerosis. II. Long-term repair. Scolding N Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1711-20. PubMed ID: 10603622 [TBL] [Abstract][Full Text] [Related]
5. Using stem cells in multiple sclerosis therapies. Muraro PA; Cassiani-Ingoni R; Martin R Cytotherapy; 2004; 6(6):615-20. PubMed ID: 15764028 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Dawson DM; Carter JL; Hafler DA; Weiner HL Riv Neurol; 1987; 57(2):88-91. PubMed ID: 3039645 [TBL] [Abstract][Full Text] [Related]
8. Enhancing central nervous system remyelination in multiple sclerosis. Dubois-Dalcq M; Ffrench-Constant C; Franklin RJ Neuron; 2005 Oct; 48(1):9-12. PubMed ID: 16202704 [TBL] [Abstract][Full Text] [Related]
9. Prospects of cell therapy for disorders of myelin. Ben-Hur T; Goldman SA Ann N Y Acad Sci; 2008 Oct; 1142():218-49. PubMed ID: 18990129 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: new treatment trials and emerging therapeutic targets. DeAngelis T; Lublin F Curr Opin Neurol; 2008 Jun; 21(3):261-71. PubMed ID: 18451708 [TBL] [Abstract][Full Text] [Related]
12. Regeneration and repair in multiple sclerosis: the role of cell transplantation. Pluchino S; Zanotti L; Brini E; Ferrari S; Martino G Neurosci Lett; 2009 Jun; 456(3):101-6. PubMed ID: 19429143 [TBL] [Abstract][Full Text] [Related]
13. Current immunotherapy of multiple sclerosis and future challenges: relevance of immune-mediated repair. Carrithers MD Curr Pharm Biotechnol; 2012 Jun; 13(8):1409-17. PubMed ID: 22339217 [TBL] [Abstract][Full Text] [Related]
16. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. Muzio L; Martino G; Furlan R J Neuroimmunol; 2007 Nov; 191(1-2):39-44. PubMed ID: 17936915 [TBL] [Abstract][Full Text] [Related]
17. [Stem cells in therapy of multiple sclerosis]. Narkilahti S; Hovatta O; Elovaara I Duodecim; 2009; 125(9):965-73. PubMed ID: 19517865 [TBL] [Abstract][Full Text] [Related]
18. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis? Hohlfeld R J Neurol Sci; 2008 Feb; 265(1-2):93-6. PubMed ID: 17459415 [TBL] [Abstract][Full Text] [Related]
19. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis. Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353 [TBL] [Abstract][Full Text] [Related]
20. The basis for treatment in multiple sclerosis. Compston A Acta Neurol Scand Suppl; 2006; 183():41-7. PubMed ID: 16637928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]